Overactive Bladder (OAB)
61
20
20
24
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.3%
2 terminated out of 61 trials
92.3%
+5.7% vs benchmark
21%
13 trials in Phase 3/4
25%
6 of 24 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 24 completed trials
Clinical Trials (61)
Long-Term Effectiveness and Safety of Sacral Neuromodulation With InterStim for Lower Urinary Tract Dysfunction
Evaluating Pumpkin Seed Oil Extract Supplementation on Bladder Function
Effectiveness of Ambulatory Transcutaneous Tibial Nerve Stimulation for Overactive Bladder
Aquarius Pilot Study to Evaluate the New Axonics Trial System
PMCF Study of the Axonics SNM System Model 5101 (R20) for the Indication of OAB
Tensi+ for Treating Overactive Bladder
Cefar URO - Symptomatic Treatment of Overactive Bladder
Peroneal Neuromodulation vs Pelvic Floor Exercises in OAB
Impact of Transcutaneous Electrical Nerve Stimulation on the Autonomic Nervous System in the Treatment of Overactive Bladder
Non-invasive Saphenous Nerve Stimulation Therapy for Overactive Bladder
RELIEVE Study: NT 201 Intravesical Administration Using Vibe System (ViXe Combination Product) for the Treatment of Idiopathic Overactive Bladder
Methenamine Hippurate Following Intradetrusor OnabotulinumtoxinA Injection
Predictive Value of Inflammatory Biomarkers for Mirabegron Response in Women With Overactive Bladder
Effect of Antimuscarinic Treatment on Premature Ejaculation Severity in Men With Overactive Bladder: a Prospective Comparison With Mirabegron
Efficacy of Transcutaneous Electrical Stimulation Therapy in the Treatment of Overactive Bladder Developing After Stroke
Bladder Training With or Without Biofeedback-Assisted Pelvic Floor Muscle Training for Women With Wet Overactive Bladder
Burden and Efficacy of Anticholinergic vs Mirabegron in Overactive Bladder - A Randomized Controlled Study
Pretibial TENS for Pain and Anxiety During Intravesical OnabotulinumtoxinA Injection
Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)
Zinc Supplementation With Botulinum Toxin for Overactive Bladder